Global Alzheimer's Disease Drug Market Insights, Forecast to 2025

Final Report will add the analysis of the impact of COVID-19 on this industryAlzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
In the last several years, global market of alzheimer’s disease drug change huge.
The classification of alzheimer’s disease drug includes Memantine, Donepezil, Rivastigmine and Others, and the proportion of Memantine in 2016 is about 49.28%. The market for Donepezil, is decreast quickly in past five years.
Alzheimer’s disease drug are widely used for Early to Moderate, Moderate to Severe stage treatment. The most proportion of alzheimer’s disease drug used to Moderate to Severe, and the market share in 2016 is 55.82%.
The global Alzheimer's Disease Drug market is valued at 2870 million US$ in 2018 and will reach 1280 million US$ by the end of 2025, growing at a CAGR of -11.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Alzheimer's Disease Drug market based on company, product type, end user and key regions.

This report studies the global market size of Alzheimer's Disease Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Alzheimer's Disease Drug in these regions.
This research report categorizes the global Alzheimer's Disease Drug market by top players/brands, region, type and end user. This report also studies the global Alzheimer's Disease Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck

Market size by Product
Donepezil
Memantine
Rivastigmine
Market size by End User
Early to Moderate Stages
Moderate to Severe Stages

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Alzheimer's Disease Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Alzheimer's Disease Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Alzheimer's Disease Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Alzheimer's Disease Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Alzheimer's Disease Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Alzheimer's Disease Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports